Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide is a dual-acting medication known as a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater who also have one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol Wegovy and Saxenda are also approved for the treatment of children age 12 and older
Two authors assessed the risk of bias for each study through five aspects: random sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting
Avoid Harsh Products: Refrain from using strong skincare products, exfoliants, or retinoids for a few days after the treatment
US$ 28.20
US$ 23.29
US$ 22.47
US$ 23.46
US$ 29.03
US$ 27.54
US$ 22.86
